Neuroaspis was presented at DGN Congress during Neurowoche 2018, 30/10-3/11 in Berlin. DGN Congress is one of the largest German-speaking medical congresses and one of the three most visited neurological congresses worldwide. https://www.dgn.org/rubrik-dgn/der-dgn-kongress

NEUROASPIS® was presented at  ECTRIMS Berlin 2018, the 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, which was held between 10-12 October in Berlin. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis.

Aniva International will be exhibiting at ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis between 10-12 October in Berlin, Germany. We look forward to meeting you there!  – Stand D11

NEUROASPIS® plp10 was presented at XI/XVII Congress of Serbian Neurologists with International Participation will was held in Belgrade from 24 to 26.11.2017 .     

NEUROASPIS® plp10 was presented at  MSParis2017, the 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France, 25-28 October 2017. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis.

NEUROASPIS® plp10 was presented at the 90th Neurology Congress of the German Society of Neurology under the motto “Mensch im Blick – Gehirn im Fokus/People in Focus – Brain in Focus” in Leipzig, Germany, 20-23 September 2017.

NEUROASPIS was awarded as one of the leading innovations in Vitafoods Europe at Poster Presentation area, which  is a unique platform specially designed to showcase excellence in nutritional science, innovation, business and education. Posters cover ground-breaking product innovations within the fields of nutraceutical ingredients, dietary supplements and new technology.

NEUROASPIS® plp10 was presented at the 6th Ohrid Neurology Congress with International Participation in Ohrid, FYROM, 21-24 September 2016.  

NEUROASPIS® plp10 was presented at ECTRIMS 2016 exhibition in London, UK during the 32ND CONGRESS OF THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS.

NEUROASPIS® Plp10 The Novel Nutraceutical Intervention as an Adjuvant Treatment for Multiple Sclerosis – “Specific PUFAs and antioxidant vitamins fulfil the criterion of biological plausibility and have the potential to diminish the severity and activity of MS symptoms, potentially even promoting recovery (remyelination)” https://www.ecronicon.com/eco16/pdf/ECNE-01-ECO-02.pdf